Allergan Sales LLC
FDA inspection history in Cincinnati, Ohio, 2019 to 2021
- 2
- Form 483s
Every document, by year
- Form 483
2019: one Form 483; 2021: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2019–21Two Form 483s, at Cincinnati, Ohio.
- 2021The longest 483 on file: 8 observations over 13 pages at Cincinnati, Ohio.
Cited most
Across all Allergan Sales observations on file
- 21 CFR 211.160General requirements2
- 21 CFR 211.166Stability testing2
- 21 CFR 211.192Production record review2
- 21 CFR 211.110(a)Sampling and testing of in-process materials and drug products1
- 21 CFR 211.165Testing and release for distribution1
The complete Allergan Sales file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Cincinnati, Ohio
Two Form 483s · 2019 to 2021 · 12 observations
Latest: Form 483, Jun 24, 2021 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2021-06-24 | 483 Form 483 | Cincinnati, Ohio | 8 | $99 |
| 2019-07-29 | 483 Form 483 | Cincinnati, Ohio | 4 | $99 |
Investigators on these documents
FEI number 1523957 · most recent document Jun 24, 2021
About Allergan Sales LLC
How many FDA Form 483s has Allergan Sales LLC received?
FDA Intel has 2 Form 483s on file for Allergan Sales LLC; the most recent is dated Jun 24, 2021.
When was Allergan Sales LLC last inspected by FDA?
The most recent FDA inspection document on file for Allergan Sales LLC is a Form 483 dated Jun 24, 2021, for the site in Cincinnati, Ohio.
What did FDA cite at Allergan Sales LLC?
The regulations cited most in the observations on file for Allergan Sales LLC are 21 CFR 211.160 (General requirements), 2 times; 21 CFR 211.166 (Stability testing), 2 times; 21 CFR 211.192 (Production record review), 2 times.